Tuesday, April 5, 2:00 PM EDT

Two thought leaders who have deep knowledge of--and experience in--biomarker testing in patients with hematologic malignancies will discuss best practices for biomarker testing in chronic lymphocytic leukemia (CLL) and multiple myeloma based on patient case discussions and the latest guidelines.

Speakers:

Lindsey Roeker, MD
Hematologic Oncologist, Memorial Sloan Kettering Cancer Center

Urvi Shah, MD
Hematologic Oncologist, Memorial Sloan Kettering Cancer Center
FREE REGISTRATION